Immunity, Inflammation, and Cancer

Cell - Tập 140 - Trang 883-899 - 2010
Sergei I. Grivennikov1, Florian R. Greten2, Michael Karin1
1Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA
22nd Department of Medicine, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany

Tài liệu tham khảo

Aggarwal, 2009, Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe, Clin. Cancer Res., 15, 425, 10.1158/1078-0432.CCR-08-0149 Ammirante, 2010, B cell-derived lymphotoxin promotes castration-resistant prostate cancer, Nature, 464, 302, 10.1038/nature08782 Andreu, 2010, FcRgamma activation regulates inflammation-associated squamous carcinogenesis, Cancer Cell, 17, 121, 10.1016/j.ccr.2009.12.019 Angel, 1987, Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor, Cell, 49, 729, 10.1016/0092-8674(87)90611-8 Apetoh, 2007, The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy, Immunol. Rev., 220, 47, 10.1111/j.1600-065X.2007.00573.x Apetoh, 2007, Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nat. Med., 13, 1050, 10.1038/nm1622 Aspord, 2007, Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development, J. Exp. Med., 204, 1037, 10.1084/jem.20061120 Balkwill, 2009, Tumour necrosis factor and cancer, Nat. Rev. Cancer, 9, 361, 10.1038/nrc2628 Becker, 2004, TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling, Immunity, 21, 491, 10.1016/j.immuni.2004.07.020 Berg, 1996, Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses, J. Clin. Invest., 98, 1010, 10.1172/JCI118861 Bollrath, 2009, gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis, Cancer Cell, 15, 91, 10.1016/j.ccr.2009.01.002 Bonecchi, 2009, Chemokines and chemokine receptors: an overview, Front. Biosci., 14, 540, 10.2741/3261 Buckowitz, 2005, Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases, Br. J. Cancer, 92, 1746, 10.1038/sj.bjc.6602534 Bui, 2007, Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?, Curr. Opin. Immunol., 19, 203, 10.1016/j.coi.2007.02.001 Calle, 2007, Obesity and cancer, BMJ, 335, 1107, 10.1136/bmj.39384.472072.80 Chang, 2006, The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover, Cell, 124, 601, 10.1016/j.cell.2006.01.021 Chen, 2008, Integration of external signaling pathways with the core transcriptional network in embryonic stem cells, Cell, 133, 1106, 10.1016/j.cell.2008.04.043 Chiorazzi, 2005, Chronic lymphocytic leukemia, N. Engl. J. Med., 352, 804, 10.1056/NEJMra041720 Colotta, 2009, Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability, Carcinogenesis, 30, 1073, 10.1093/carcin/bgp127 Condeelis, 2006, Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, 124, 263, 10.1016/j.cell.2006.01.007 Cooper, 2009, Concepts of epigenetics in prostate cancer development, Br. J. Cancer, 100, 240, 10.1038/sj.bjc.6604771 Crowe, 2005, Differential antitumor immunity mediated by NKT cell subsets in vivo, J. Exp. Med., 202, 1279, 10.1084/jem.20050953 de Martel, 2009, Infections and cancer: established associations and new hypotheses, Crit. Rev. Oncol. Hematol., 70, 183, 10.1016/j.critrevonc.2008.07.021 De Santa, 2007, The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing, Cell, 130, 1083, 10.1016/j.cell.2007.08.019 de Visser, 2006, Paradoxical roles of the immune system during cancer development, Nat. Rev. Cancer, 6, 24, 10.1038/nrc1782 Degenhardt, 2006, Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis, Cancer Cell, 10, 51, 10.1016/j.ccr.2006.06.001 DeNardo, 2009, CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages, Cancer Cell, 16, 91, 10.1016/j.ccr.2009.06.018 Dostert, 2008, Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica, Science, 320, 674, 10.1126/science.1156995 Dougan, 2009, Immune therapy for cancer, Annu. Rev. Immunol., 27, 83, 10.1146/annurev.immunol.021908.132544 Dunn, 2004, The immunobiology of cancer immunosurveillance and immunoediting, Immunity, 21, 137, 10.1016/j.immuni.2004.07.017 Dunn, 2006, Interferons, immunity and cancer immunoediting, Nat. Rev. Immunol., 6, 836, 10.1038/nri1961 Dvorak, 1986, Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing, N. Engl. J. Med., 315, 1650, 10.1056/NEJM198612253152606 Edwards, 2009, Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer, Cancer Res., 69, 6423, 10.1158/0008-5472.CAN-09-1285 Eferl, 2003, AP-1: a double-edged sword in tumorigenesis, Nat. Rev. Cancer, 3, 859, 10.1038/nrc1209 Enzler, 2003, Deficiencies of GM-CSF and interferon gamma link inflammation and cancer, J. Exp. Med., 197, 1213, 10.1084/jem.20021258 Enzler, 2009, Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression, Blood, 114, 4469, 10.1182/blood-2009-06-230169 Erdman, 2005, CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice, Cancer Res., 65, 3998, 10.1158/0008-5472.CAN-04-3104 Ernst, 2008, STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice, J. Clin. Invest., 118, 1727 Ershler, 2000, Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty, Annu. Rev. Med., 51, 245, 10.1146/annurev.med.51.1.245 Fearon, 1990, A genetic model for colorectal tumorigenesis, Cell, 61, 759, 10.1016/0092-8674(90)90186-I Ferreri, 2009, Infectious agents and lymphoma development: molecular and clinical aspects, J. Intern. Med., 265, 421, 10.1111/j.1365-2796.2009.02083.x Fridlender, 2009, Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN, Cancer Cell, 16, 183, 10.1016/j.ccr.2009.06.017 Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat. Rev. Immunol., 9, 162, 10.1038/nri2506 Gallimore, 2008, Positive and negative influences of regulatory T cells on tumour immunity, Oncogene, 27, 5886, 10.1038/onc.2008.269 Galon, 2006, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Science, 313, 1960, 10.1126/science.1129139 Gao, 2007, Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas, J. Clin. Invest., 117, 3846, 10.1172/JCI31871 Ghiringhelli, 2009, Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors, Nat. Med., 15, 1170, 10.1038/nm.2028 Gierach, 2008, Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study, Breast Cancer Res., 10, R38, 10.1186/bcr2089 Granziero, 2001, Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia, Blood, 97, 2777, 10.1182/blood.V97.9.2777 Greten, 2004, IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer, Cell, 118, 285, 10.1016/j.cell.2004.07.013 Greten, 2007, NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta, Cell, 130, 918, 10.1016/j.cell.2007.07.009 Grivennikov, 2010, Dangerous liasons: STAT3 and NF-kappaB collaboration and crosstalk in cancer, Cytokine Growth Factor Rev., 1, 11, 10.1016/j.cytogfr.2009.11.005 Grivennikov, 2009, IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer, Cancer Cell, 15, 103, 10.1016/j.ccr.2009.01.001 Guerra, 2007, Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice, Cancer Cell, 11, 291, 10.1016/j.ccr.2007.01.012 Guidoboni, 2001, Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis, Am. J. Pathol., 159, 297, 10.1016/S0002-9440(10)61695-1 Gupta, 2001, Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2, Nat. Rev. Cancer, 1, 11, 10.1038/35094017 Hahn, 2008, Methylation of polycomb target genes in intestinal cancer is mediated by inflammation, Cancer Res., 68, 10280, 10.1158/0008-5472.CAN-08-1957 Hanada, 2006, IFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice, J. Exp. Med., 203, 1391, 10.1084/jem.20060436 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Haybaeck, 2009, A lymphotoxin-driven pathway to hepatocellular carcinoma, Cancer Cell, 16, 295, 10.1016/j.ccr.2009.08.021 Hedvat, 2009, The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors, Cancer Cell, 16, 487, 10.1016/j.ccr.2009.10.015 Hodge, 2005, The role of IL-6 and STAT3 in inflammation and cancer, Eur. J. Cancer, 41, 2502, 10.1016/j.ejca.2005.08.016 Hurst, 2009, Injectable collagenase clostridium histolyticum for Dupuytren's contracture, N. Engl. J. Med., 361, 968, 10.1056/NEJMoa0810866 Hussain, 2003, Radical causes of cancer, Nat. Rev. Cancer, 3, 276, 10.1038/nrc1046 Joyce, 2009, Microenvironmental regulation of metastasis, Nat. Rev. Cancer, 9, 239, 10.1038/nrc2618 Kalluri, 2009, The basics of epithelial-mesenchymal transition, J. Clin. Invest., 119, 1420, 10.1172/JCI39104 Kaplan, 2005, VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, 438, 820, 10.1038/nature04186 Karin, 2006, Nuclear factor-kappaB in cancer development and progression, Nature, 441, 431, 10.1038/nature04870 Kastritis, 2009, Treatment of relapsed/refractory multiple myeloma, Semin. Hematol., 46, 143, 10.1053/j.seminhematol.2009.01.004 Khasawneh, 2009, Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion, Proc. Natl. Acad. Sci. USA, 106, 3354, 10.1073/pnas.0802864106 Kim, 2009, Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis, Nature, 457, 102, 10.1038/nature07623 Kitamura, 2007, SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion, Nat. Genet., 39, 467, 10.1038/ng1997 Koebel, 2007, Adaptive immunity maintains occult cancer in an equilibrium state, Nature, 450, 903, 10.1038/nature06309 Kohrt, 2005, Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer, PLoS Med., 2, e284, 10.1371/journal.pmed.0020284 Kortylewski, 2005, Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity, Nat. Med., 11, 1314, 10.1038/nm1325 Kortylewski, 2009, Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment, Cancer Cell, 15, 114, 10.1016/j.ccr.2008.12.018 Kraus, 2009, Inflammation and colorectal cancer, Curr. Opin. Pharmacol., 9, 405, 10.1016/j.coph.2009.06.006 Kujawski, 2008, Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice, J. Clin. Invest., 118, 3367, 10.1172/JCI35213 Laghi, 2009, CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study, Lancet Oncol., 10, 877, 10.1016/S1470-2045(09)70186-X Langowski, 2006, IL-23 promotes tumour incidence and growth, Nature, 442, 461, 10.1038/nature04808 Langowski, 2007, Swords into plowshares: IL-23 repurposes tumor immune surveillance, Trends Immunol., 28, 207, 10.1016/j.it.2007.03.006 Lewis, 2006, Distinct role of macrophages in different tumor microenvironments, Cancer Res., 66, 605, 10.1158/0008-5472.CAN-05-4005 Liao, 2009, Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model, PLoS ONE, 4, e7965, 10.1371/journal.pone.0007965 Lin, 2007, A cytokine-mediated link between innate immunity, inflammation, and cancer, J. Clin. Invest., 117, 1175, 10.1172/JCI31537 Lin, 2009, The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling, Oncogene, 28, 961, 10.1038/onc.2008.448 Liu, 2006, Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha, Am. J. Epidemiol., 164, 984, 10.1093/aje/kwj294 Luo, 2004, Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression, Cancer Cell, 6, 297, 10.1016/j.ccr.2004.08.012 Luo, 2007, Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin, Nature, 446, 690, 10.1038/nature05656 Lust, 2009, Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1beta-induced interleukin 6 production and the myeloma proliferative component, Mayo Clin. Proc., 84, 114, 10.4065/84.2.114 Maeda, 2005, IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis, Cell, 121, 977, 10.1016/j.cell.2005.04.014 Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205 Martin-Orozco, 2009, T helper 17 cells promote cytotoxic T cell activation in tumor immunity, Immunity, 31, 787, 10.1016/j.immuni.2009.09.014 McDonald, 2009, Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms, Int. J. Cancer, 125, 1298, 10.1002/ijc.24409 Meira, 2008, DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice, J. Clin. Invest., 118, 2516 Moore, 1999, Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis, Nat. Med., 5, 828, 10.1038/10552 Murdoch, 2008, The role of myeloid cells in the promotion of tumour angiogenesis, Nat. Rev. Cancer, 8, 618, 10.1038/nrc2444 Musteanu, 2010, Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice, Gastroenterology, 138, 1003, 10.1053/j.gastro.2009.11.049 Naugler, 2007, Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production, Science, 317, 121, 10.1126/science.1140485 Nguyen, 2009, Metastasis: from dissemination to organ-specific colonization, Nat. Rev. Cancer, 9, 274, 10.1038/nrc2622 Nickoloff, 2005, Inflammation and cancer: is the link as simple as we think?, J. Invest. Dermatol., 124, x, 10.1111/j.0022-202X.2005.23724.x O'Reilly, 2009, Membrane-bound Fas ligand only is essential for Fas-induced apoptosis, Nature, 461, 659, 10.1038/nature08402 Oguma, 2008, Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells, EMBO J., 27, 1671, 10.1038/emboj.2008.105 Okayasu, 1996, Promotion of colorectal neoplasia in experimental murine ulcerative colitis, Gut, 39, 87, 10.1136/gut.39.1.87 Okazaki, 2007, Role of AID in tumorigenesis, Adv. Immunol., 94, 245, 10.1016/S0065-2776(06)94008-5 Orimo, 2006, Stromal fibroblasts in cancer: a novel tumor-promoting cell type, Cell Cycle, 5, 1597, 10.4161/cc.5.15.3112 Orimo, 2005, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell, 121, 335, 10.1016/j.cell.2005.02.034 Pagès, 2005, Effector memory T cells, early metastasis, and survival in colorectal cancer, N. Engl. J. Med., 353, 2654, 10.1056/NEJMoa051424 Palucka, 2007, Taming cancer by inducing immunity via dendritic cells, Immunol. Rev., 220, 129, 10.1111/j.1600-065X.2007.00575.x Palumbo, 2007, Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms, Blood, 110, 133, 10.1182/blood-2007-01-065995 Park, 2010, Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression, Cell, 140, 197, 10.1016/j.cell.2009.12.052 Pedersen, 2002, Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1, Blood, 100, 1795, 10.1182/blood.V100.5.1795.h81702001795_1795_1801 Pikarsky, 2004, NF-kappaB functions as a tumour promoter in inflammation-associated cancer, Nature, 431, 461, 10.1038/nature02924 Polyak, 2009, Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits, Nat. Rev. Cancer, 9, 265, 10.1038/nrc2620 Popivanova, 2008, Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis, J. Clin. Invest., 118, 560 Punturieri, 2009, Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research, J. Natl. Cancer Inst., 101, 554, 10.1093/jnci/djp023 Rakoff-Nahoum, 2009, Toll-like receptors and cancer, Nat. Rev. Cancer, 9, 57, 10.1038/nrc2541 Rius, 2008, NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha, Nature, 453, 807, 10.1038/nature06905 Roberts, 2007, Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis, Proc. Natl. Acad. Sci. USA, 104, 6770, 10.1073/pnas.0604982104 Rodier, 2009, Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nat. Cell Biol., 11, 973, 10.1038/ncb1909 Ruzankina, 2009, Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53, Nat. Genet., 41, 1144, 10.1038/ng.441 Sakurai, 2008, Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis, Cancer Cell, 14, 156, 10.1016/j.ccr.2008.06.016 Shankaran, 2001, IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, 410, 1107, 10.1038/35074122 Shibata, 2010, Conditional deletion of IkappaB-kinase beta accelerates Helicobacter-dependent gastric apoptosis, proliferation and preneoplasia, Gastroenterology, 138, 1022, 10.1053/j.gastro.2009.11.054 Shime, 2008, Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway, J. Immunol., 180, 7175, 10.4049/jimmunol.180.11.7175 Shojaei, 2007, Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells, Nat. Biotechnol., 25, 911, 10.1038/nbt1323 Sica, 2008, Cancer related inflammation: the macrophage connection, Cancer Lett., 267, 204, 10.1016/j.canlet.2008.03.028 Sieweke, 1990, Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta, Science, 248, 1656, 10.1126/science.2163544 Smyth, 2000, Differential tumor surveillance by natural killer (NK) and NKT cells, J. Exp. Med., 191, 661, 10.1084/jem.191.4.661 Smyth, 2003, Nature's TRAIL—on a path to cancer immunotherapy, Immunity, 18, 1, 10.1016/S1074-7613(02)00502-2 Smyth, 2006, Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity, Adv. Immunol., 90, 1, 10.1016/S0065-2776(06)90001-7 Soucek, 2007, Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors, Nat. Med., 13, 1211, 10.1038/nm1649 Sparmann, 2004, Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis, Cancer Cell, 6, 447, 10.1016/j.ccr.2004.09.028 Stockmann, 2008, Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis, Nature, 456, 814, 10.1038/nature07445 Strid, 2008, Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis, Nat. Immunol., 9, 146, 10.1038/ni1556 Swann, 2007, Immune surveillance of tumors, J. Clin. Invest., 117, 1137, 10.1172/JCI31405 Swann, 2008, Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis, Proc. Natl. Acad. Sci. USA, 105, 652, 10.1073/pnas.0708594105 Swann, 2009, Type I natural killer T cells suppress tumors caused by p53 loss in mice, Blood, 113, 6382, 10.1182/blood-2009-01-198564 Takahashi, 2010, Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta and JNK1-dependent inflammation, Cancer Cell, 17, 89, 10.1016/j.ccr.2009.12.008 Takai, 2009, A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations, Oncogene, 28, 469, 10.1038/onc.2008.415 Trinchieri, 2003, The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses, Immunity, 19, 641, 10.1016/S1074-7613(03)00296-6 Tu, 2008, Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice, Cancer Cell, 14, 408, 10.1016/j.ccr.2008.10.011 Tuncman, 2006, Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance, Proc. Natl. Acad. Sci. USA, 103, 10741, 10.1073/pnas.0603509103 Umar, 2009, Functional cross-talk between beta-catenin and NFkappaB signaling pathways in colonic crypts of mice in response to progastrin, J. Biol. Chem., 284, 22274, 10.1074/jbc.M109.020941 Vakkila, 2004, Inflammation and necrosis promote tumour growth, Nat. Rev. Immunol., 4, 641, 10.1038/nri1415 Waldner, 2009, Colitis-associated cancer: the role of T cells in tumor development, Semin. Immunopathol., 31, 249, 10.1007/s00281-009-0161-8 Wang, 2009, IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway, J. Exp. Med., 206, 1457, 10.1084/jem.20090207 Wong, 2009, High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B, Int. J. Cancer, 124, 2766, 10.1002/ijc.24281 Wu, 2009, A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses, Nat. Med., 15, 1016, 10.1038/nm.2015 Wu, 2009, Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion, Cancer Cell, 15, 416, 10.1016/j.ccr.2009.03.016 Yang, 2008, Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis, Dev. Cell, 14, 818, 10.1016/j.devcel.2008.05.009 Yang, 2008, Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis, Cancer Cell, 13, 23, 10.1016/j.ccr.2007.12.004 Yu, 2007, Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment, Nat. Rev. Immunol., 7, 41, 10.1038/nri1995 Yu, 2009, STATs in cancer inflammation and immunity: a leading role for STAT3, Nat. Rev. Cancer, 9, 798, 10.1038/nrc2734 Zhang, 2004, NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK, Genes Dev., 18, 17, 10.1101/gad.1160904 Zhang, 2007, Induced sensitization of tumor stroma leads to eradication of established cancer by T cells, J. Exp. Med., 204, 49, 10.1084/jem.20062056 Zheng, 2007, Fen1 mutations result in autoimmunity, chronic inflammation and cancers, Nat. Med., 13, 812, 10.1038/nm1599 Zitvogel, 2008, Immunological aspects of cancer chemotherapy, Nat. Rev. Immunol., 8, 59, 10.1038/nri2216 Zong, 2006, Necrotic death as a cell fate, Genes Dev., 20, 1, 10.1101/gad.1376506